Samuel D. Isaly, Director at Intellia Therapeutics, Inc. (NTLA), bought 814,780 shares at $18.00 ($4.5M) on 2016-05-11, disclosed to the SEC on 2016-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 564,780 | $0 | 0.0% |
| 2 | $18.00 | 58,534 | $1.1M | 23.4% |
| 3 | $18.00 | 191,466 | $3.4M | 76.6% |
| Total | $5.52 avg | 814,780 | $4.5M | 100% |
| Filing → |
| RYTM | BUY | 2017-10-10 | $6.0M | — | Filing → |
| BOLD | SELL | 2017-09-29 | $19.0M | — | Filing → |
| ROKA | SELL | 2017-09-28 | $202K | — | Filing → |